4/17
03:02 am
dhr
Danaher Co. (NYSE: DHR) was given a new $231.00 price target on by analysts at Robert W. Baird.
Low
Report
Danaher Co. (NYSE: DHR) was given a new $231.00 price target on by analysts at Robert W. Baird.
4/16
01:14 pm
dhr
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight [Yahoo! Finance]
Low
Report
Global In-Vitro Diagnostics Market Predicted to Surpass the USD 90 Billion Mark by 2032 | DelveInsight [Yahoo! Finance]
4/13
05:58 pm
dhr
Is Danaher Corporation (DHR) the Best Medical Stock to Buy According to Billionaires? [Yahoo! Finance]
Low
Report
Is Danaher Corporation (DHR) the Best Medical Stock to Buy According to Billionaires? [Yahoo! Finance]
4/10
01:41 pm
dhr
Oxford Nanopore inks infectious disease analysis pact with Cepheid [Yahoo! Finance]
Low
Report
Oxford Nanopore inks infectious disease analysis pact with Cepheid [Yahoo! Finance]
4/9
07:38 am
dhr
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions [Yahoo! Finance]
High
Report
Cepheid and Oxford Nanopore Technologies Partner to Advance Automated Sequencing-Based Solutions [Yahoo! Finance]
4/7
08:44 am
dhr
ALZpath Named 2025 BRONZE Edison Award Winner for its Proprietary pTau217 Antibody, a Key Biomarker Driving Blood-Based Alzheimer's Disease Diagnostics [Yahoo! Finance]
Low
Report
ALZpath Named 2025 BRONZE Edison Award Winner for its Proprietary pTau217 Antibody, a Key Biomarker Driving Blood-Based Alzheimer's Disease Diagnostics [Yahoo! Finance]
4/7
08:13 am
dhr
Danaher Co. (NYSE: DHR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
Low
Report
Danaher Co. (NYSE: DHR) had its "buy" rating re-affirmed by analysts at Citigroup Inc..
4/3
09:32 am
dhr
Anatomic Pathology Market to Reach USD 74.64 Billion by 2032, Driven by Rising Cancer Prevalence and Technological Advancements in Diagnostics | SNS Insider [Yahoo! Finance]
Low
Report
Anatomic Pathology Market to Reach USD 74.64 Billion by 2032, Driven by Rising Cancer Prevalence and Technological Advancements in Diagnostics | SNS Insider [Yahoo! Finance]
4/3
01:34 am
dhr
Danaher Corporation (DHR): One of the Best Healthcare Stocks to Buy According to Billionaires [Yahoo! Finance]
Low
Report
Danaher Corporation (DHR): One of the Best Healthcare Stocks to Buy According to Billionaires [Yahoo! Finance]
4/1
10:36 am
dhr
High Content Screening Market worth US$2.19 billion in 2030 with 7.5% CAGR | MarketsandMarkets™ [Yahoo! Finance]
Low
Report
High Content Screening Market worth US$2.19 billion in 2030 with 7.5% CAGR | MarketsandMarkets™ [Yahoo! Finance]
3/31
09:24 am
dhr
Integrated DNA Technologies and Elegen Partner to Revolutionize Long DNA Synthesis Market [Yahoo! Finance]
Neutral
Report
Integrated DNA Technologies and Elegen Partner to Revolutionize Long DNA Synthesis Market [Yahoo! Finance]
3/26
07:00 am
dhr
SprintRay Expands Digital Dentistry Portfolio in Europe with Midas Digital Press and New Material Innovations at IDS 2025 [Yahoo! Finance]
Low
Report
SprintRay Expands Digital Dentistry Portfolio in Europe with Midas Digital Press and New Material Innovations at IDS 2025 [Yahoo! Finance]
3/25
12:12 pm
dhr
Phenomenex Introduces Biozen™ Native RP-1 and RP-5: A Novel Way to Characterize ADCs with Unmatched Throughput and High-Quality Data [Yahoo! Finance]
Low
Report
Phenomenex Introduces Biozen™ Native RP-1 and RP-5: A Novel Way to Characterize ADCs with Unmatched Throughput and High-Quality Data [Yahoo! Finance]
3/24
07:06 am
dhr
High Content Screening/Imaging Market Analysis 2025-2029: Increasing R&D Budgets, Emerging Economies and Technological Advances Fueling Opportunities [Yahoo! Finance]
Low
Report
High Content Screening/Imaging Market Analysis 2025-2029: Increasing R&D Budgets, Emerging Economies and Technological Advances Fueling Opportunities [Yahoo! Finance]
3/22
07:06 pm
dhr
Danaher Corporation (DHR): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil [Yahoo! Finance]
Low
Report
Danaher Corporation (DHR): Among Stocks Wall Street Is Calling Bullish Amid Market Turmoil [Yahoo! Finance]
3/21
08:09 am
dhr
Danaher Co. (NYSE: DHR) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $260.00 price target on the stock.
Low
Report
Danaher Co. (NYSE: DHR) was upgraded by analysts at The Goldman Sachs Group, Inc. from a "neutral" rating to a "buy" rating. They now have a $260.00 price target on the stock.
3/20
04:31 pm
dhr
Danaher Schedules First Quarter 2025 Earnings Conference Call [Yahoo! Finance]
Low
Report
Danaher Schedules First Quarter 2025 Earnings Conference Call [Yahoo! Finance]
3/20
04:15 pm
dhr
Danaher Schedules First Quarter 2025 Earnings Conference Call
Low
Report
Danaher Schedules First Quarter 2025 Earnings Conference Call
3/20
03:26 am
dhr
BioPorto announces the Annual Report for 2024 [Yahoo! Finance]
Low
Report
BioPorto announces the Annual Report for 2024 [Yahoo! Finance]
3/19
07:38 am
dhr
Food & Beverages Coding and Marking Equipment Market Report 2025: Set to Reach $2.66 Billion by 2033 Driven by Mandated Regulations and Tech Innovations [Yahoo! Finance]
Low
Report
Food & Beverages Coding and Marking Equipment Market Report 2025: Set to Reach $2.66 Billion by 2033 Driven by Mandated Regulations and Tech Innovations [Yahoo! Finance]
3/18
06:18 am
dhr
X-Rite Brings End-to-End Color Innovation to European Coatings Show [Yahoo! Finance]
Low
Report
X-Rite Brings End-to-End Color Innovation to European Coatings Show [Yahoo! Finance]
3/18
06:00 am
dhr
X-Rite Brings End-to-End Color Innovation to European Coatings Show
Low
Report
X-Rite Brings End-to-End Color Innovation to European Coatings Show
3/14
08:02 am
dhr
Danaher Co. (NYSE: DHR) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $260.00 price target on the stock.
Medium
Report
Danaher Co. (NYSE: DHR) was upgraded by analysts at Stifel Nicolaus from a "hold" rating to a "buy" rating. They now have a $260.00 price target on the stock.
3/10
09:06 am
dhr
Global Trade Complexities Fuel Growth for Coupa's AI-Native Total Spend Management Platform [Yahoo! Finance]
Low
Report
Global Trade Complexities Fuel Growth for Coupa's AI-Native Total Spend Management Platform [Yahoo! Finance]
3/10
09:04 am
dhr
Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System [Yahoo! Finance]
Low
Report
Beckman Coulter Announces FDA clearance of DxC 500i Clinical Analyzer, an integrated Clinical Chemistry and Immunoassay System [Yahoo! Finance]